Amyris Inc. (NASDAQ:AMRS)
Amyris Inc. (NASDAQ:AMRS) has had a long and tumultuous history. The organization’s first venture was to specialist microorganisms to deliver artemisinin, a cure for intestinal sickness. It then wandered on to deliver energizes the same way, which seemed well and good with 2007 oil costs, yet does not bode well today.
En route, it took in a considerable measure about how to both make yeast strains that create an assortment of chemicals, and how to make biofactories (presented underneath) with the goal that a lot of these chemicals can be delivered. While a few organizations have fiddled